Chemokines and antitumor immunity: walking the tightrope.
about
Impact of Tumor-Derived CCL2 on Macrophage Effector FunctionTumor-secreted PGE2 inhibits CCL5 production in activated macrophages through cAMP/PKA signaling pathway.CXCR6: the role of environment in tumor progression. Challenges for therapy.Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progression.Secondary lymphoid-tissue chemokine induced modulation of T cells.
P2860
Chemokines and antitumor immunity: walking the tightrope.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Chemokines and antitumor immunity: walking the tightrope.
@ast
Chemokines and antitumor immunity: walking the tightrope.
@en
type
label
Chemokines and antitumor immunity: walking the tightrope.
@ast
Chemokines and antitumor immunity: walking the tightrope.
@en
prefLabel
Chemokines and antitumor immunity: walking the tightrope.
@ast
Chemokines and antitumor immunity: walking the tightrope.
@en
P2860
P356
P1476
Chemokines and antitumor immunity: walking the tightrope.
@en
P2093
Mark S Brault
Robert A Kurt
P2860
P304
P356
10.1080/08830180305224
P577
2003-05-01T00:00:00Z